Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLONAZEPAM vs CLOXACILLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLONAZEPAM vs CLOXACILLIN: Safety Overview

Metric CLONAZEPAM CLOXACILLIN
Total FAERS Reports 39,463 994
Deaths Reported 8,488 106
Death Rate 21.5% 10.7%
Hospitalizations 12,506 618
Average Patient Age 46.0 yrs 60.0 yrs
% Female Patients 58.3% 37.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Advagen Pharma Ltd N/A
Route ORAL N/A
Marketing Status Prescription Discontinued